Drugs News and Research

RSS

Acupuncture and Turmeric could be viable treatment options for arthritis sufferers

People who suffer from osteoarthritis (OA) as a rule find it has to varying degrees an impact on their mobility and quality of life.

31 Oct 2006

HIV/AIDS and poverty in Zambia threatens economic growth

HIV/AIDS and poverty in Zambia "are threatening" economic growth the country has achieved since gaining its independence in 1964, President Levy Mwanawasa said last week in a speech on the eve of Zambia's 42nd anniversary of independence, Reuters reports.

30 Oct 2006

Sequencing of chemotherapy and radiation therapy for early breast cancer

For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.

30 Oct 2006

Israeli physicians share HIV/AIDS treatment methods with Ethiopian colleagues

Israeli physicians who gained experience treating Ethiopian immigrants living with HIV/AIDS in Israel are sharing techniques for treating HIV/AIDS with Ethiopian physicians, Reuters reports.

30 Oct 2006

Acupuncture in patients with osteoarthritis of the knee or hip

Osteoarthritis (OA) has a major impact on patients' mobility and quality of life but the anti-inflammatory drugs used to treat it are associated with a number of side effects.

30 Oct 2006

South Africa shifts response to HIV/AIDS epidemic

The South African government has shifted its response to the HIV/AIDS epidemic to focus more on expanding access to antiretroviral treatment, HIV testing and prevention, the Washington Post reports.

30 Oct 2006

Most U.S. residents do not examine source, date of health care data posted online

Three-fourths of U.S. adults who search for health care information online regularly do not examine the source and date to determine the quality of the data, according to a survey released on Sunday by the Pew Internet & American Life Project, Reuters/Boston Globe reports.

30 Oct 2006

Effective test for screening Huntington's disease drugs

A test using cultured cells provides an effective way to screen drugs against Huntington's disease and shows that two compounds - memantine and riluzole - are most effective at keeping cells alive under conditions that mimic the disorder, UT Southwestern Medical Center researchers report.

30 Oct 2006

Self-assembling nanoparticle releases drug into cell cytoplasm

A growing body of research leaves no doubt that nanoparticles can transport drugs into cancer cells, but what is less clear is that the drug payload can exit the tiny endosomes that pull nanoparticles into cells.

30 Oct 2006

Global Fund To Fight AIDS, Tuberculosis and Malaria needs improved oversight of programs

The Global Fund To Fight AIDS, Tuberculosis and Malaria needs to improve its oversight of programs in developing countries and find ways to ensure that programs it funds are effective, according to a report released on Wednesday by the Center for Global Development, the Boston Globe reports.

26 Oct 2006

In the case of an outbreak of pandemic flu, large majority of Americans willing to make major changes in their lives

The latest national survey conducted by the Harvard School of Public Health (HSPH) Project on the Public and Biological Security finds that when faced with a serious outbreak of pandemic flu, a large majority of Americans are willing to make major changes in their lives and cooperate with public health officials' recommendations.

26 Oct 2006

Big pharma contributes millions to Republican congressional campaigns in close races

The Wall Street Journal on Wednesday examined how pharmaceutical companies are "pouring millions of dollars" into congressional campaigns in close races, "giving some Republicans a financial edge."

26 Oct 2006

Scientists step toward next generation of cancer-beating drugs

Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.

From The University of Manchester 26 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006